We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.75 | -12.24% | 5.375 | 5.00 | 5.75 | 6.25 | 5.125 | 6.25 | 2,491,017 | 12:44:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.20 | 6.18M |
From Apr 2023 to Apr 2024
TIDMGDR
RNS Number : 0413B
Genedrive PLC
31 May 2023
genedrive plc
("genedrive" or the "Company")
Block Listing Returns
The Company confirms the block listing six monthly return for the period to 31 May 2023.
Hot Features
Premium
Name of applicant genedrive plc
Name of scheme 2007 Share Option Scheme
-------------------------------------------
Period of return: From: 01 December To: 31 May 2023
2022
------------------ ------------ ---- -----------------------
Balance of unallocated securities 139,226 shares
under scheme(s) from previous
return:
-------------------------------------------
Plus: The amount by which the Nil
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------------
Less: Number of securities issued/allotted 7,500 shares
under scheme(s) during period
(see LR3.5.7G):
-------------------------------------------
Equals: Balance under scheme(s) 131,726 shares
not yet issued/allotted at end
of period:
-------------------------------------------
In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.
Name of applicant genedrive plc
Name of scheme 2017 Share Option Scheme
-------------------------------------------
Period of return: From: 19 May 2023 To: 31 May 2023
------------------ ------------ ---- -----------------------
Balance of unallocated securities 1,150,588 shares
under scheme(s) from previous
return:
-------------------------------------------
Plus: The amount by which the Nil
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------------
Less: Number of securities issued/allotted Nil
under scheme(s) during period
(see LR3.5.7G):
-------------------------------------------
Equals: Balance under scheme(s) 1,150,588 shares
not yet issued/allotted at end
of period:
-------------------------------------------
Name of applicant genedrive plc
Name of scheme Unapproved Share Option Scheme
-------------------------------------------
Period of return: From: 19 May 2023 To: 31 May 2023
------------------- ------------ ---- -----------------------
Balance of unallocated securities 2,668,144 shares
under scheme(s) from previous
return:
-------------------------------------------
Plus: The amount by which the Nil
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------------
Less: Number of securities issued/allotted Nil
under scheme(s) during period
(see LR3.5.7G):
-------------------------------------------
Equals: Balance under scheme(s) 2,668,144 shares
not yet issued/allotted at end
of period:
-------------------------------------------
Name of contact: Russ Shaw CFO
-------------------------------------------
Telephone number of contact: +44 (0)161 989 0245
-------------------------------------------
For enquires:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Russ Shaw: CFO
Peel Hunt LLP (Nominated Adviser
and Joint Broker) +44 (0)20 7418 8900
James Steel / Oliver Duckworth
finnCap (Joint Broker) +44 (0)20 7220 500
Geoff Nash / George Dollemore / Nigel
Birks / Alice Lane
Walbrook PR Ltd (Media Relations +44 (0)20 7933 8780 or genedrive@walbrookpr.com
& Investor Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRFLFILETIIVIV
(END) Dow Jones Newswires
May 31, 2023 02:00 ET (06:00 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
